Global Tropicamide Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Tropicamide Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Tropicamide, sold under the brand name Mydriacyl among others, is a medication used to dilate the pupil and help with examination of the eye. Specifically it is used to help examine the back of the eye. It is applied as eye drops. Effects occur within 40 minutes and last for up to a day.
Tropicamide report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tropicamide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Tropicamide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Tropicamide key manufacturers include Alcon Laboratories, Akorn, Bausch Health, Miza Pharmaceuticals, Watson Laboratories, Novartis, Dioptic Pharmaceuticals, Roemmers and Thea Pharma, etc. Alcon Laboratories, Akorn, Bausch Health are top 3 players and held % sales share in total in 2022.
Tropicamide can be divided into 5mg and 10mg, etc. 5mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Tropicamide is widely used in various fields, such as Hospital and Drug Store, etc. Hospital provides greatest supports to the Tropicamide industry development. In 2022, global % sales of Tropicamide went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tropicamide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Alcon Laboratories
Akorn
Bausch Health
Miza Pharmaceuticals
Watson Laboratories
Novartis
Dioptic Pharmaceuticals
Roemmers
Thea Pharma
Vega Pharma
Agepha Pharma
Pharma Stulln
Visufarma
Unimed Pharma
Edol
Polfa Warszawa
Laboratorios Sophia
Nippon Tenganyaku Kenkyujo
Wakamoto
Chauvin Ankerpharm
Segment by Type
5mg
10mg
Hospital
Drug Store
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Tropicamide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Tropicamide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Tropicamide industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Tropicamide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Tropicamide introduction, etc. Tropicamide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Tropicamide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Tropicamide report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tropicamide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Tropicamide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Tropicamide key manufacturers include Alcon Laboratories, Akorn, Bausch Health, Miza Pharmaceuticals, Watson Laboratories, Novartis, Dioptic Pharmaceuticals, Roemmers and Thea Pharma, etc. Alcon Laboratories, Akorn, Bausch Health are top 3 players and held % sales share in total in 2022.
Tropicamide can be divided into 5mg and 10mg, etc. 5mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Tropicamide is widely used in various fields, such as Hospital and Drug Store, etc. Hospital provides greatest supports to the Tropicamide industry development. In 2022, global % sales of Tropicamide went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tropicamide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Alcon Laboratories
Akorn
Bausch Health
Miza Pharmaceuticals
Watson Laboratories
Novartis
Dioptic Pharmaceuticals
Roemmers
Thea Pharma
Vega Pharma
Agepha Pharma
Pharma Stulln
Visufarma
Unimed Pharma
Edol
Polfa Warszawa
Laboratorios Sophia
Nippon Tenganyaku Kenkyujo
Wakamoto
Chauvin Ankerpharm
Segment by Type
5mg
10mg
Segment by Application
Hospital
Drug Store
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Tropicamide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Tropicamide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Tropicamide industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Tropicamide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Tropicamide introduction, etc. Tropicamide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Tropicamide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.